The First Crispr Medicine Just Got Approved

The first medical treatment that uses Crispr gene editing was authorized Thursday by the United Kingdom.

The one-time therapy, which will be sold under the brand name Casgevy, is for patients with sickle cell disease and a related blood disorder called beta thalassemia, both of which are inherited. The UK approval marks a historic moment for Crispr, the molecular equivalent of scissors that won its inventors a Nobel Prize in 2020.

Developed by Vertex Pharmaceuticals of Boston and Crispr Therapeutics of Switzerland, Casgevy is meant to prevent episodes of excruciating pain that are typical of sickle cell disease and free people with beta thalassemia of regular blood transfusions. The treatment involves

→ Continue reading at Wired - Science

More from author

Related posts

Advertisment

Latest posts

A Surge in Babies Born With Syphilis Is a Warning Sign

The US is enduring a sharp spike in cases of babies born with syphilis, an illness that not only threatens infants’ health, but also...

Dr. Alison Todd’s Inventions May Save Your Life

Dr. Alison Todd describes herself as an “inventor at heart,” but she’s not the sort of inventor who tinkers with gears in a workshop....

Mars is buying a specialist British chocolate maker in UK push | CNN Business

London CNN  —  Mars is buying Britain’s Hotel Chocolat in a deal that values the specialist chocolate maker at...